Understanding how certain immune cells respond to HIV
Defining the biological relevance of HIV specific HLA-E restricted CD8 T cell responses
This study is looking at how a special type of immune cell helps the body fight HIV, and it's for anyone interested in understanding more about HIV and how we might improve vaccines to better protect against it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10813754 on NIH RePORTER |
What this research studies
This research investigates the role of HLA-E restricted CD8 T cells in the immune response to HIV. By examining how these specific immune cells recognize and respond to HIV peptides, the study aims to fill a significant gap in our understanding of HIV immunity. The researchers are utilizing advanced biological reagents to analyze the effectiveness of these T cells in chronic HIV infection, which could lead to new insights for vaccine development. The approach is based on previous findings in other viral infections, suggesting that these immune cells may play a crucial role in controlling HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with chronic HIV infection who have a diverse immune response.
Not a fit: Patients who are not infected with HIV or those with acute HIV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccine strategies and better immune responses against HIV.
How similar studies have performed: While the role of HLA-E restricted CD8 T cells has shown promise in other viral infections, this specific investigation into HIV is relatively novel and has not been extensively studied.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Goepfert, Paul a. — University of Alabama at Birmingham
- Study coordinator: Goepfert, Paul a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.